Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.
NCT ID: NCT01008436
Last Updated: 2012-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
400 participants
INTERVENTIONAL
2010-01-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The two populations are followed up prospectively as regarding blood loss and need for blood transfusions, as well as adverse events at 30 days after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding
NCT02640235
Dilutional Coagulopathy in Patients Undergoing Elective Surgery
NCT00493272
PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery
NCT03131336
Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery
NCT05523297
Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.
NCT07278661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Traditional best-practice surgical hemostasis
Control
Traditional surgical Hemostasis
Omni-stat Celox
Administration of 6 gr of Omni-stat Celox intraoperatively at the time of Hemostasis
Omni-stat Celox
Topical administration of 6 gr of Omnistat Celox
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Omni-stat Celox
Topical administration of 6 gr of Omnistat Celox
Control
Traditional surgical Hemostasis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiochirurgia E.H.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luca Weltert
Project Leader Luca Weltert
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European Hospital
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.